期刊文献+

结构脂肪乳剂在高胆红素血症患者中应用的安全性研究 被引量:1

Safety of structured triglyceride used in treatment of hyperbilirubinemia patients:A comparative study
下载PDF
导出
摘要 目的比较结构脂肪乳剂(STG)和物理混合的中/长链脂肪乳剂(MCT/LCT)在高胆红素血症患者中应用的安全性。方法回顾性分析2008年-2009年25对高胆红素血症(术后当天血清总胆红素200-400μ mol/L)术后肠外营养应用脂肪乳≥5d的患者,STG组25例,MCT/LCT组25例。结果与使用脂肪乳前比较,两组使用脂肪乳后第1天和第5天谷丙转氨酶(ALT),谷草转氨酶(AST),碱性磷酸酶(AKP),γ-GT及胆红素均有所下降(P<0.05),甘油三酯无明显变化(P>0.05)。两组患者使用后第1天和第5天血生化指标无明显差异(P>0.05)。结论结构脂肪乳剂在高胆红素血症患者中应用对肝功能的影响与物理混合MCT/LCT无明显差异。 Objective To compare the safety of structured triglyceride(STG) and physically mixed medium chain triglyceride/long chain triglyceride(MCT/LCT) used in treatment of hyperbilirubinemia patients.Methods Fifty hyperbilirubinemia patients admitted to our hospital from 2008 to 2009 with a serum total bilirubin of 200-400μmol/L on the postoperative day were divided into STG group(n=25) and MCT/LCT group(n=5).Their parenteral STB and MCT/LCT nutrition in patients for≥5 days was retrospectively analyzed.Results The ALT,AST,AKP,γ-GT and bilirubin levels were significantly lower in the two groups 1 and 5 days after the STG and MCT/LCT were used than before they were used(P〈0.05).However,no significant difference was found in triglyceride between the two groups(P〉0.05).Conclusion The effects of STG and MCT/LCT are not significantly different on the liver function of hyperbilirubinemic patients.
出处 《军医进修学院学报》 CAS 2011年第12期1235-1236,1244,共3页 Academic Journal of Pla Postgraduate Medical School
基金 解放军总医院科技创新苗圃基金(11KMZ04)
关键词 结构脂肪乳剂 高胆红素血症 物理混合中/长链脂肪乳剂 structolipid hyperbilirubinemia physical mixed MCT/LCT
  • 相关文献

参考文献5

  • 1刘剑煌,刘景丰.梗阻性黄疸肝再生受损机制[J].医学综述,2008,14(14):2151-2154. 被引量:1
  • 2Wanten GJ,Calder PC.Immune modulation by parenteral lipidemulsions[J].Am J Clin Nutr,2007,85(5):1171-1184.
  • 3Rubin M,Moser A,Vaserberg N,et al.Structured triacylglycerolemulsion,containing both medium-and long-chain fatty acids,inlong-term home parenteral nutrition:a double-blind randomizedcross-over study[J].Nutrition,2000,16(2):95-100.
  • 4Kruimel JW,Naber TH,van der Vliet JA,et al.Parenteralstructured triglyceride emulsion improves nitrogen balance and iscleared faster from the blood in moderately catabolic patients[J].JParenter Enteral Nutr,2001,25(5):237-244.
  • 5Chambrier C,Lauverjat M,Bouletreau P.Structured triglycerideemulsions in parenteral nutrition[J].Nutr Clin Pract,2006,21(4):342-350.

二级参考文献2

同被引文献24

  • 1王新颖,李宁,谭力,邹志英,江志伟,黎介寿.结构脂肪乳剂对腹部中等手术后病人脂肪代谢的影响[J].肠外与肠内营养,2006,13(4):209-211. 被引量:15
  • 2施咏梅,费旭峰,蒋咏梅,王晔,商俊,曹伟新.结构脂肪乳对蛋白质和脂质代谢的影响[J].上海医学,2006,29(8):534-537. 被引量:7
  • 3DECKELBAUM RJ,CALDER PC,CARPENTIER YA.Using different intravenous lipids:underutilized therapeutic approaches?[J].Curr Opin Clin Nutr Metab Care,2004,7(2):113-115.
  • 4DAN LW.Evolution of parenteral lipid emulsions[J].Clin Nutr Suppl,2005,1(1):5-7.
  • 5JADAD AR,MOORE RA,CARROLL D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J].Control Clin Trials,1996,17(1):1-12.
  • 6EGGER M,SMITH GD.Bias in location and selection of studies[J].BMJ,1998,316(7124):61-66.
  • 7SANDSTROM R,HYLTANDER A,KORNER U,et al.Structured triglycerides to postoperative patients:a safety and tolerance study[J].JPEN J Parenter Enteral Nutr,1993,17(2):153-157.
  • 8SANDSTROM R,HYLTANDER A,KORNER U,et al.Structured triglycerides were well tolerated and induced increased whole body fat oxidation compared with long-chain triglycerides in postoperative patients[J].JPEN J Parenter Enteral Nutr,1995,19(5):381-386.
  • 9CHAMBRIER C,GUIRAUD M,GIBAULT JP,et al.Mediumand long-chain triacylglycerols in postoperative patients:structured lipids versus a physical mixture-a safety and tolerance study[J].Nutrition,1999,15(4):274-277.
  • 10BELLANTONE R,BOSSOLA M,CARRIERO C,et al.Structured versus long-chain triglycerides:a safety,tolerance,and efficacy randomized study in colorectal surgical patients[J].JPEN J Parenter Enteral Nutr,1999,23(3):123-127.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部